Compare Cytokinetics Inc (CYTK) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Pinterest Inc — how do they compare? Cytokinetics Inc trades at $82.61 (market cap $11.12B), while Pinterest Inc trades at $23.66 (market cap $12.66B). The key difference: Cytokinetics Inc and Pinterest Inc are close in size by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | PINS | |
|---|---|---|
Market Cap | $11.12B | $12.66B |
Sector | Technology | Media |
52-Week High | $87.26 | $39.17 |
52-Week Low | $33.23 | $15.42 |
Enterprise Value | $11.59B | $12.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $82.24, down 3.1% today, with a bullish technical outlook supported by moving averages and RSI near oversold levels. The company shows strong analyst support with 97% buy ratings and a $110.40 consensus target, but faces fundamental challenges with a -784% net income margin and negative cash flow from operations of -$510M in 2025. Recent positive developments include FDA approval and European launch of Myqorzo, driving commercial momentum.
Outlook remains speculative with high valuation (P/S 93.92) against significant losses, yet growth potential exists if Myqorzo gains market traction. Key risks include cash burn, competitive pressure, and reliance on single drug success. Institutional sentiment is overwhelmingly bullish, but investors must weigh high risk-reward profile amid ongoing profitability challenges.
Pinterest (PINS) trades at $22.6, up 0.31% on the day, with a bullish technical outlook and strong analyst consensus. Revenue grew to $4.22B in 2025, with net income of $417M, though Q2 2026 earnings are pending. Recent news highlights AI-driven shopping features and user growth, supporting positive sentiment.
The stock offers upside to the $27.72 consensus target, but high valuation ratios and recent insider selling pose risks. Earnings consistency and competitive pressures in social media remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
